• SENSEX
    NIFTY 50
Business

SPARC licenses commercialisation rights of anti-epileptic drug to Tripoint Therapeutics

Updated : September 22, 2020 10:32 AM IST

SPARC licenses commercialisation rights of anti-epileptic drug to Tripoint Therapeutics

You May Also Like

Live TV

recommended for you

Advertisement